GOT1 and hyperlipidemia: The observed significant increase (p < 0.001) in the levels of biomarkers, i.e., AST/SGOT, ALT/SGPT, ALP, total cholesterol, LDL, VLDL, triglycerides, total bilirubin, and atherogenic index [39–41] and a significant decrease (p < 0.001) of HDL level in serum of Cd treated rats is the evidence of hepatotoxicity and hyperlipidemia [42].